ESSEX WOODLANDS HEALTH VENTURES FUND VI L P 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed Feb 26, 2009
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2009-02-26$0.05/sh−4,236,586$218,608→ 1,161,812 total - Sale
Common Stock
2009-02-24$0.07/sh−2,164,033$159,922→ 7,584,610 total - Sale
Common Stock
2009-02-25$0.06/sh−2,186,211$138,824→ 5,398,399 total
Footnotes (3)
- [F1]Represents the weighted average sale price of shares purchased by the Reporting Person in the price range of $0.07 to $0.10. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- [F2]Represents the weighted average sale price of shares purchased by the Reporting Person in the price range of $0.06 to $0.07. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- [F3]Represents the weighted average sale price of shares purchased by the Reporting Person in the price range of $0.05 to $0.06. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.